| Primary |
| Cardiac Stress Test |
45.0% |
| Scan Myocardial Perfusion |
12.5% |
| Cardiac Imaging Procedure |
6.3% |
| Exercise Test |
6.3% |
| Cardiac Pharmacologic Stress Test |
3.8% |
| Chest Pain |
3.8% |
| Coronary Artery Disease |
3.8% |
| Cardiac Function Test |
2.5% |
| Familial Risk Factor |
2.5% |
| Arrhythmia |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Chest Discomfort |
1.3% |
| Congestive Cardiomyopathy |
1.3% |
| Diabetes Mellitus |
1.3% |
| Electrocardiogram Abnormal |
1.3% |
| Exercise Electrocardiogram |
1.3% |
| Hypertension |
1.3% |
| Myocardial Ischaemia |
1.3% |
| Parathyroid Disorder |
1.3% |
| Product Used For Unknown Indication |
1.3% |
|
| Urticaria |
19.0% |
| Rash |
13.1% |
| Vomiting |
13.1% |
| Swollen Tongue |
6.0% |
| Vision Blurred |
6.0% |
| Drug Ineffective |
3.6% |
| Dysgeusia |
3.6% |
| Nausea |
3.6% |
| Swelling Face |
3.6% |
| Tremor |
3.6% |
| Wheezing |
3.6% |
| Anaphylactic Reaction |
2.4% |
| Angioedema |
2.4% |
| Blood Glucose Increased |
2.4% |
| Blood Pressure Increased |
2.4% |
| Dizziness |
2.4% |
| Flushing |
2.4% |
| Hypersensitivity |
2.4% |
| Hypoglycaemia |
2.4% |
| Pruritus |
2.4% |
|
| Secondary |
| Cardiac Stress Test |
25.8% |
| Scan Myocardial Perfusion |
17.2% |
| Diabetes Mellitus |
8.6% |
| Product Used For Unknown Indication |
8.6% |
| Blood Cholesterol Increased |
4.3% |
| Blood Pressure Management |
4.3% |
| Diabetic Neuropathy |
4.3% |
| Diuretic Therapy |
4.3% |
| Gout |
4.3% |
| Pain |
4.3% |
| Renal Disorder |
4.3% |
| Chest Pain |
2.2% |
| Arrhythmia |
1.1% |
| Cardiac Pharmacologic Stress Test |
1.1% |
| Chest Discomfort |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Familial Risk Factor |
1.1% |
| Pain In Extremity |
1.1% |
| Tachycardia |
1.1% |
|
| Vomiting |
21.7% |
| Infusion Site Pain |
8.7% |
| Unresponsive To Stimuli |
8.7% |
| Atrioventricular Block Complete |
4.3% |
| Blood Pressure Increased |
4.3% |
| Hypersensitivity |
4.3% |
| Impetigo |
4.3% |
| Injection Site Ulcer |
4.3% |
| Oral Pruritus |
4.3% |
| Orthostatic Hypotension |
4.3% |
| Procedural Complication |
4.3% |
| Retching |
4.3% |
| Skin Exfoliation |
4.3% |
| Speech Disorder |
4.3% |
| Swelling Face |
4.3% |
| Vein Disorder |
4.3% |
| Vision Blurred |
4.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.0% |
| Breast Cancer Metastatic |
12.3% |
| Metastatic Neoplasm |
12.3% |
| Diabetes Mellitus |
8.5% |
| Hypersensitivity |
8.5% |
| Coronary Artery Bypass |
6.9% |
| Scan Myocardial Perfusion |
6.9% |
| Cardiac Stress Test |
3.1% |
| Aortic Valve Replacement |
1.5% |
| Catheterisation Cardiac |
1.5% |
| Echocardiogram |
1.5% |
| Lung Transplant |
1.5% |
| Chest Pain |
0.8% |
| Cox-maze Procedure |
0.8% |
| Mitral Valve Replacement |
0.8% |
| Muscle Spasms |
0.8% |
| Pain |
0.8% |
| Post Procedural Haemorrhage |
0.8% |
| Stress |
0.8% |
|
| Anxiety |
9.7% |
| Muscle Spasms |
9.7% |
| Tenosynovitis Stenosans |
9.7% |
| Cardiopulmonary Failure |
6.5% |
| Hepatic Steatosis |
6.5% |
| Injury |
6.5% |
| Pain |
6.5% |
| Supraventricular Tachycardia |
6.5% |
| Atrioventricular Block Second Degree |
3.2% |
| Cardiac Arrest |
3.2% |
| Death |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Dyspnoea |
3.2% |
| Emotional Distress |
3.2% |
| Gait Disturbance |
3.2% |
| Haematoma |
3.2% |
| Heart Rate Increased |
3.2% |
| Hypermetabolism |
3.2% |
| Lymphoma |
3.2% |
| Mental Status Changes |
3.2% |
|
| Interacting |
| Arthralgia |
33.3% |
| Costochondritis |
33.3% |
| Investigation |
33.3% |
|
|
